Clinical Trials Browser

INDUSTRY × Liver Neoplasms × brivanib × Clear all

NCT00825955 2019-10-09

BRISK PS

Phase 3 Completed

Gastrointestinal

Liver Neoplasms

NCT00437424 2011-05-04

A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver Dysfunction

Phase 1 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms